PSYCHOSIS 273 18. Investigate Sleep-Inducing Medications with the Physician ( 18) A. The client's treating physician was consulted regarding the need for sleep-inducing medications to provide the client and his/her caregivers time to regroup relative to this curren t psychotic episode. B. The treating physician has prescribed sleep-inducing medications that have helped the client to sleep, which has resulted in a more reality-based orientation. C. Caregivers were supported for providing intensive support to the cli ent subsequent to his/her being induced to sleep. D. The treating physician has declined to use sleep-inducing medication. 19. Educate about Psychotropic Medications ( 19) A. The client was taught about the indications for and the expected benefits of ps ychotropic medications. B. As the client's psychotropic medications were reviewed, he/she displayed an understanding about the indications for and expected benefits of the medications. C. The client displayed a lack of understanding of the indications fo r and expected benefits of psychotropic medications and was provided with additional information and feedback regarding his/her medications. 20. Monitor Medications (2 0) A. The client was monitored for compliance with his/her psychotropic medication regi men. B. The client was provided with positive feedback about his/her regular use of psychotropic medications. C. The client was monitored for the effectiveness and side effects of his/her prescribed medications. D. Concerns about the client's medication effectiveness and side effects were communicated to the physician. E. Although the client was monitored for medication side effects, he/she reported no concerns in this area. 21. Review Side Effects of Medications (2 1) A. The possible side effects rela ted to the client's medications were reviewed with the client. B. The client identified significant side effects, and these were reported to the medical staff. C. Possible side effects of the client's medications were reviewed, but he/she denied experien cing any side effects. 22. Assess Tardive Symptoms (2 2) A. Arrangements were made for an assessment of the client's tardive symptoms. B. Objective measurement of the client's tardive symptoms was performed by qualified personnel using a specific instrum ent [e. g., the Abnormal Involuntary Movement Scale (AIMS)]. C. The client displayed no evidence of tardive symptoms, and this was reflected to him/her. D. The client displayed both subjective and objective evidence of tardive symptoms, and this was repor ted to the physician who prescribed the client's psychotropic medications. 